Changes in uveitis treatment during the pandemic may increase risk of relapse

• Posted on: Jan 13 2021
• By: Saratoga Opthalmology
• Leave a response

This multicenter, prospective case series evaluated changes in ongoing immunomodulatory and biologic therapies used for noninfectious uveitis during the COVID-19 pandemic.
Source: AAO

Posted in: Uncategorized